Determination and pharmacokinetic studies of arecoline in dog plasma by liquid chromatography-tandem mass spectrometry

J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Oct 15:969:12-8. doi: 10.1016/j.jchromb.2014.07.043. Epub 2014 Aug 8.

Abstract

A rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated for the determination of arecoline concentration in dog plasma. Plasma sample was prepared by protein precipitation using n-hexane (containing 1% isoamyl alcohol) with β-pinene as an internal standard. Chromatographic separation was achieved on an Agilent C18 column (4.6×75mm, 3.5μm) using methanol: 5mM ammonium acetate as the mobile phase with isocratic elution. Mass detection was carried out using positive electrospray ionization in multiple reaction monitoring mode. The calibration curve for arecoline was linear over a concentration range of 2-500ng/mL. The intra-day and inter-day accuracy and precision were within the acceptable limits of ±10% at all concentrations. In summary, the LC-MS/MS method described herein was fully validated and successfully applied to the pharmacokinetic study of arecoline hydrobromide tablets in dogs after oral administration.

Keywords: Arecoline hydrobromide; Arecoline hydrobromide tablets; Dog plasma; LC–MS/MS; Pharmacokinetics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arecoline / blood*
  • Arecoline / chemistry
  • Arecoline / pharmacokinetics*
  • Chromatography, High Pressure Liquid / methods*
  • Dogs
  • Female
  • Limit of Detection
  • Linear Models
  • Male
  • Reproducibility of Results
  • Tandem Mass Spectrometry / methods*

Substances

  • Arecoline